Single User License
INR 135700
Site License
INR 265278
Corporate User License
INR 407100

Service Tax Additional

select a format
Price

Single User License
USD 1995
Site License
USD 3900
Corporate User License
USD 5985

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-France

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-France


  Request for Sample Report

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-France

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-France". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

France's population grew from 64 million in 2008 to 65.5 million in 2013, mainly due to a rising life expectancy (INSEE, 2014e). The increasingly elderly population and its associated disease burden have been fueling the growth of the pharmaceutical market, which, although it fell from USD 48.9 billion in 2008 to USD 44.1 billion in 2012 at a negative Compound Annual Growth Rate (CAGR) of 1.2% in US dollar terms, increased at a CAGR of 0.7% in euro terms between 2008 and 2013 (INSEE, 2014r). In 2008, the medical device market was worth USD 12.7 billion, which increased to USD 15.5 billion in 2013 and is projected to grow at a CAGR of 5.1% to USD 21.8 billion in 2020.

These positive growth trends can primarily be attributed to-

Government initiatives in the healthcare sector

Universal healthcare coverageIncreasingly elderly population

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes-

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Pfizer, Novartis, AstraZeneca and Merck; and profiles and SWOT analyses of the major players in the medical device market: Medtronic, F. Hoffmann-La Roche, Siemens Healthcare, Essilor and Abbott

Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the French healthcare market

Reasons To Buy

This report will enhance your decision-making capability by allowing you to-

Develop business strategies by understanding the trends shaping and driving France's healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect France's healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership

Identify, understand, and capitalize on the opportunities and challenges in France's healthcare market

1 Table of Contents

1 Table of Contents 6

1.1 List of Tables 10

1.2 List of Figures 15

2 Introduction 20

2.1 GlobalData Report Guidance 20

3 Overview of Pharmaceutical and Medical Device Market 21

3.1 Pharmaceutical Market 21

3.1.1 Market Overview 21

3.1.2 Pharmaceutical Exports and Imports 23

3.1.3 Supply Channels 25

3.1.4 Market Segments 26

3.1.5 Major Therapeutic Areas 33

3.1.6 Major Players 36

3.2 Medical Device Market 77

3.2.1 Market Overview 77

3.2.2 Overview of Top Five Segments 79

3.2.3 Diagnostics Market 94

3.2.4 Major Players 96

3.3 Market Drivers and Barriers 129

3.3.1 Drivers 129

3.3.2 Barriers 131

4 Market Access 133

4.1 Reimbursement and Payer Landscape 133

4.1.1 Overview of Healthcare system 133

4.1.2 Reimbursement Process 135

4.1.3 Overview of Insurance Providers 141

4.1.4 Patient Share in Healthcare Expenditure 145

4.1.5 Price Trends in the Healthcare Sector 147

4.1.6 Pricing Policies 148

4.2 Regulatory Landscape 150

4.2.1 Overview of Regulatory Agencies 150

4.2.2 Market Authorization Procedure for Pharmaceutical Products 151

4.2.3 New Medical Device Approval Process 161

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 165

4.2.5 Exports and Imports 166

4.2.6 Intellectual Property Rights 167

4.2.7 Clinical Trial Regulations 172

4.2.8 Pharmaceutical Advertising Regulations 172

4.2.9 Pharmacy Regulations 173

4.2.10 Labeling and Packaging Regulations 175

5 Country Analysis 177

5.1 Political Environment 177

5.1.1 Political Structure 177

5.1.2 Analysis of Current Political Environment 178

5.1.3 Healthcare Policy Initiatives 179

5.2 Economic Landscape 181

5.3 Economic Indicators 182

5.3.1 Gross Domestic Product 182

5.3.2 Gross National Income 186

5.3.3 Inflation 187

5.3.4 Currency Exchange Rate 192

5.3.5 Foreign Direct Investment 193

5.3.6 Foreign Exchange Reserves 195

5.3.7 Trade Balance 196

5.3.8 Government Structural Balance 198

5.3.9 Government Net Debt 200

5.3.10 Major Industries 201

5.4 Demographics 202

5.4.1 Population 202

5.4.2 Education and Literacy 220

5.4.3 Employment 223

5.4.4 Disease Burden 225

5.5 Healthcare Infrastructure 226

5.5.1 Healthcare Facilities 226

5.5.2 Healthcare Parameters 231

5.5.3 Environmental Health 233

5.5.4 Healthcare Personnel 240

5.6 Healthcare Expenditure 244

5.6.1 Overview 244

5.6.2 Share of Public and Private Sectors 245

5.6.3 Major Components of Healthcare Expenditure 247

5.6.4 Spending in Pharmaceutical R&D 248

5.7 Trade Associations 250

5.7.1 France Biotech 250

5.7.2 French Medical Device Association 251

5.7.3 French Pharmaceutical Association 251

5.8 Trade Fairs 252

6 Opportunities and Challenges 253

6.1 Opportunities 253

6.2 Challenges 254

7 Appendix 256

7.1 Abbreviations 256

7.2 Bibliography 260

7.3 Research Methodology 276

7.3.1 Coverage 276

7.3.2 Secondary Research 277

7.3.3 Forecasts 277

7.3.4 Expert Panel 277

7.4 Disclaimer 278

1.2 List of Figures

Figure 1: Pharmaceutical Market, France, Revenue (USD bn), 2008-2013 22

Figure 2: Pharmaceutical Market, France, Revenue Forecast (USD bn), 2014-2020 23

Figure 3: Pharmaceutical Market, France, Exports and Imports (USD bn), 2008-2013 24

Figure 4: Pharmaceutical Market, France, Distribution Channels (%), 2009 25

Figure 5: Pharmaceutical Market, France, Generic Pharmaceutical Market Share (%), 2008-2013 27

Figure 6: Pharmaceutical Market, France, OTC Drug Market Revenue (USD bn), 2008-2013 31

Figure 7: Pharmaceutical Market, France, Major OTC Drug Classes, Revenue (USD m), 2013 32

Figure 8: Pharmaceutical Market, France, Major Therapeutic Areas, Revenue Share (%), 2011 33

Figure 9: Medical Device Market, France, Revenue (USD bn), 2008-2013 78

Figure 10: Medical Device Market, France, Revenue Forecast (USD bn), 2014-2020 79

Figure 11: Medical Device Market, France, Revenue by Segment (USD bn), 2013 80

Figure 12: Medical Device Market, France, In Vitro Diagnostics Device Market (USD m), 2008-2013 81

Figure 13: Medical Device Market, France, In Vitro Diagnostics Device Market, Sales Trends for Major Players, 2008-2012 82

Figure 14: Medical Device Market, France, Cardiovascular Device Market (USD m), 2008-2013 84

Figure 15: Medical Device Market, France, Cardiovascular Device Market, Sales Trends for Major Players, 2008-2012 85

Figure 16: Medical Device Market, France, Ophthalmic Device Market (USD m), 2008-2013 87

Figure 17: Medical Device Market, France, Ophthalmic Device Market, Sales Trends for Major Players, 2008-2012 88

Figure 18: Medical Device Market, France, Orthopedic Device Market (USD m), 2008-2013 90

Figure 19: Medical Device Market, France, Orthopedic Device Market, Sales Trends for Major Players (USD m), 2008-2012 91

Figure 20: Medical Device Market, France, Hospital Supplies Market (USD m), 2008-2013 92

Figure 21: Medical Device Market, France, Hospital Supplies Market, Sales Trends for Major Players (USD m), 2008-2012 93

Figure 22: Medical Device Market, France, Diagnostics Market, Revenue (USD bn), 2008-2013 95

Figure 23: Medical Device Market, France, Diagnostic Market Revenue, Forecast (USD bn), 2014-2020 96

Figure 24: Medical Device Market, France, Major Medical Device Companies, Revenue (USD m), 2012 97

Figure 25: Healthcare Market, France, Drivers and Barriers, 2014 132

Figure 26: Market Access, France, Healthcare System, 2014 134

Figure 27: Market Access, France, Key Influencers in Reimbursement Procedure, 2014 135

Figure 28: Market Access, France, Pricing and Reimbursement Process, 2014 136

Figure 29: Market Access, France, Roles of Transparency Commission in Reimbursement Procedure, 2014 138

Figure 30: Market Access, France, Pricing Procedure, 2014 140

Figure 31: Market Access, France, Public Health Insurance Schemes, 2011 143

Figure 32: Market Access, France, Source of Public Health Insurance Funding (%), 2013 144

Figure 33: Healthcare Expenditure, France, Out-of-Pocket Expenditure (%), 2008-2013 146

Figure 34: Market Access, France, Healthcare Consumer Price Index Annual Change (%), 2008-2013 147

Figure 35: Market Access, France, Organizational Structure of the Drug Regulatory Authority, 2014 151

Figure 36: Market Access, EU, Centralized Procedure for Market Authorization, Pre-Submission, 2012 155

Figure 37: Market Access, EU, Centralized Procedure, Market Authorization, Pre-Opinion Phase, 2012 156

Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Post-Opinion Phase, 2012 157

Figure 39: Market Access, EU, Decentralized Procedure, Market Authorization, 2012 159

Figure 40: Market Access, EU, Mutual Recognition Procedure, Market Authorization, 2012 160

Figure 41: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2014 162

Figure 42: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2014 163

Figure 43: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2014 164

Figure 44: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2014 165

Figure 45: Market Access, France, Patent Approval Process, 2014 169

Figure 46: Market Access, France, Trademark Approval Process, 2014 171

Figure 47: Economic Indicators, France, GDP Per Capita (USD ), 2008-2013 183

Figure 48: Economic Indicators, France, GDP per Capita (USD ), Forecast, 2014-2020 184

Figure 49: Economic Indicators, France, GDP Annual Growth (%), 2008-2013 185

Figure 50: Economic Indicators, France, GDP Annual Growth (%), Forecast, 2014-2020 186

Figure 51: Economic Indicators, France, GNI per Capita (USD ), 2008-2013 187

Figure 52: Economic Indicators, France, Consumer Price Index, 2008-2013 188

Figure 53: Economic Indicators, France, Average Consumer Price Index, Forecast, 2014-2020 189

Figure 54: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), 2008-2013 190

Figure 55: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020 191

Figure 56: Economic Indicators, France, Currency Exchange Rate (EUR/USD ), 2008-2013 192

Figure 57: Economic Indicators, France, Foreign Direct Investment (USD bn), 2008-2013 194

Figure 58: Economic Indicators, France, Foreign Exchange Reserves (USD bn), 2008-2013 195

Figure 59: Economic Indicators, France, Imports of Goods and Services (USD bn), 2008-2013 196

Figure 60: Economic Indicators, France, Exports of Goods and Services (USD bn), 2008-2013 198

Figure 61: Economic Indicators, France, Government Structural Balance (USD bn), 2008-2013 199

Figure 62: Economic Indicators, France, General Government Net Debt (USD bn), 2008-2013 200

Figure 63: Economic Indicators, France, Major Industries, Industrial Sector, Gross Value Added (USD bn), 2011-2012 201

Figure 64: Demographics, France, Population (million), 2008-2013 203

Figure 65: Demographics, France, Population Forecast (million), 2014-2020 204

Figure 66: Demographics, France, Population, Urban and Rural Population Share (%), 2008-2013 205

Figure 67: Demographics, France, Population, Urban and Rural Population Share Forecast (%), 2014-2020 206

Figure 68: Demographics, France, Population Distribution by Age Group (%), 2008-2013 207

Figure 69: Demographics, France, Population Distribution by Age Group Forecast (%), 2014-2020 208

Figure 70: Demographics, France, Births (per 1,000 Population), 2008-2013 209

Figure 71: Demographics, France, Mortality (per 1,000 Population), 2008-2013 210

Figure 72: Demographics, France, Major Causes of Mortality (%), 2008 212

Figure 73: Demographics, France, Children

Figure 74: Demographics, France, Immunization Rate (%), 2008-2013 215

Figure 75: Demographics, France, Major Causes of Male Mortality (per 1,000 population), 2008 216

Figure 76: Demographics, France, Major Causes of Female Mortality (per 1,000 population), 2008 217

Figure 77: Demographics, France, Gender Ratio (M/F), 2008-2013 218

Figure 78: Demographics, France, Life Expectancy at Birth (Years), 2008-2013 220

Figure 79: Demographics, France, Number of Students by Level of Education (million), 2013-2014 221

Figure 80: Demographics, France, Student Enrollment by Specialization (per 1,000 population), 2013 222

Figure 81: Demographics, France, Unemployment Rate (%), 2008-2013 224

Figure 82: Demographics, France, Major Diseases, DALYs (per 100,000 Population), 2004 225

Figure 83: Healthcare Infrastructure, France, Public and Private Hospitals, 2008-2013 227

Figure 84: Healthcare Infrastructure, France, Public and Private Hospitals Beds (�000), 2008-2013 228

Figure 85: Healthcare Infrastructure, France, Diagnostic Centers, 2008-2013 229

Figure 86: Healthcare Infrastructure, France, Diagnostic Units, 2008-2013 230

Figure 87: Healthcare Infrastructure, France, Hospitals Beds (per 1,000 Population), 2008-2013 231

Figure 88: Healthcare Infrastructure, France, Physicians (per 1,000 Population), 2008-2013 232

Figure 89: Healthcare Infrastructure, France, PM10 (�g/m�), 2008-2013 234

Figure 90: Healthcare Infrastructure, France, CO2 Emissions (Million Metric Tons), 2008-2013 235

Figure 91: Healthcare Infrastructure, France, Nitrate and Orthophosphate Content (%), 2008-2013 237

Figure 92: Healthcare Infrastructure, France, Solid Waste (Million Tons), 2008-2013 238

Figure 93: Healthcare Infrastructure, France, Nature of Collected Waste (%), 2010 239

Figure 94: Healthcare Infrastructure, France, Waste Handling (%), 2012 240

Figure 95: Healthcare Infrastructure, France, Nurses (per 100,000 Population), 2008-2013 241

Figure 96: Healthcare Infrastructure, France, Pharmacists (per 100,000 Population), 2008-2013 242

Figure 97: Healthcare Infrastructure, France, Dentists (per 100,000 Population), 2008-2013 243

Figure 98: Healthcare Infrastructure, France, Healthcare Expenditure (% of GDP), 2008-2013 245

Figure 99: Healthcare Infrastructure, France, Public-Private Share (%), 2008-2013 246

Figure 100: Healthcare Infrastructure, France, Major Components of Healthcare Expenditure (%), 2012 247

Figure 101: Healthcare Infrastructure, France, Pharmaceutical R&D Expenditure (USD bn), 2008-2013 249

Figure 102: Healthcare Infrastructure, France, Pharmaceutical R&D Expenditure (%), 2011 250

Figure 103: Healthcare Market, France, Opportunities and Challenges, 2014 255

1.1 List of Tables

Table 1: Pharmaceutical Market, France, Revenue (USD bn), 2008-2013 22

Table 2: Pharmaceutical Market, France, Revenue Forecast (USD bn), 2014-2020 23

Table 3: Pharmaceutical Market, France, Exports and Imports (USD bn), 2008-2013 24

Table 4: Pharmaceutical Market, France, Distribution Channels (%), 2009 26

Table 5: Pharmaceutical Market, France, Generic Pharmaceutical Market Share (%), 2008-2013 28

Table 6: Pharmaceutical Market, France, Major Generic Products, Volume (million boxes), 2012 28

Table 7: Pharmaceutical Market, France, Major Generic Products, Value (USD m), 2012 28

Table 8: Pharmaceutical Market, France, OTC Drug Market Revenue (USD bn), 2008-2013 31

Table 9: Pharmaceutical Market, France, Major OTC Drug Classes, Revenue (USD m) and Share (%), 2013 32

Table 10: Pharmaceutical Market, France, Major Therapeutic Areas, Revenue Share (%), 2011 34

Table 11: Pharmaceutical Market, Sanofi, Global, Major Products, 2013 37

Table 12: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 38

Table 13: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2013 43

Table 14: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 44

Table 15: Pharmaceutical Market, Novartis, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2013 51

Table 16: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018 52

Table 17: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue (USD bn) and Annual Growth (%), 2013 62

Table 18: Pharmaceutical Market, AstraZeneca, Global, Late-stage Pipeline*, 2014 63

Table 19: Pharmaceutical Market, Merck, Global, Major Products, Revenue (USD bn) and Annual Growth (%), 2013 70

Table 20: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2014 71

Table 21: Medical Device Market, France, Revenue (USD bn), 2008-2013 78

Table 22: Medical Device Market, France, Revenue Forecast (USD bn), 2014-2020 79

Table 23: Medical Device Market, France, Revenue by Segment, 2013 80

Table 24: Medical Device Market, France, In Vitro Diagnostics Device Market (USD m), 2008-2013 82

Table 25: Medical Device Market, France, In Vitro Diagnostics Device Market, Sales Trends for Major Players, 2012 83

Table 26: Medical Device Market, France, Cardiovascular Device Market (USD m), 2008-2013 84

Table 27: Medical Device Market, France, Cardiovascular Device Market, Sales Trends for Major Players, 2012 85

Table 28: Medical Device Market, France, Ophthalmic Device Market (USD m), 2008-2013 87

Table 29: Medical Device Market, France, Ophthalmic Device Market, Sales Trends for Major Players, 2012 88

Table 30: Medical Device Market, France, Orthopedic Device Market (USD m), 2008-2013 90

Table 31: Medical Device Market, France, Orthopedic Device Market, Sales Trends for Major Players (USD m), 2012 91

Table 32: Medical Device Market, France, Hospital Supplies Market (USD m), 2008-2013 93

Table 33: Medical Device Market, France, Hospital Supplies Market, Sales Trends for Major Players (USD m), 2012 94

Table 34: Medical Device Market, France, Diagnostics Market, Revenue (USD bn), 2008-2013 95

Table 35: Medical Device Market, France, Diagnostic Market Revenue, Forecast (USD bn), 2014-2020 96

Table 36: Medical Device Market, France, Major Medical Device Companies, Revenue (USD m) and Share (%), 2012 97

Table 37: Medical Device Market, Medtronic, Global, Major Products, 2013 99

Table 38: Medical Device Market, F. Hoffmann-La Roche, Global, Major Products, 2014 107

Table 39: Medical Device Market, Abbott, Global, Major Products, 2013 123

Table 40: Medical Device Market, Abbott, Global, Late-Stage Pipeline, 2014 124

Table 41: Market Access, France, Drug Reimbursement Categories and Rates (%), 2011 140

Table 42: Market Access, France, Source of Public Health Insurance Funding (%), 2013 144

Table 43: Healthcare Expenditure, France, Out-of-Pocket Expenditure (%), 2008-2013 146

Table 44: Market Access, France, Healthcare Consumer Price Index Annual Change (%), 2008-2013 148

Table 45: Market Access, France, Patent Application Fee EUR (USD ), 2014 168

Table 46: Market Access, France, Trademark Registration Fee EUR (USD ), 2014 171

Table 47: Market Access, France, Pharmacist Requirement by Revenue of Pharmacy (USD m), 2014 174

Table 48: Economic Indicators, France, GDP per Capita (USD ), 2008-2013 183

Table 49: Economic Indicators, France, GDP per Capita (USD ), Forecast, 2014-2020 184

Table 50: Economic Indicators, France, GDP Annual Growth (%), 2008-2013 185

Table 51: Economic Indicators, France, GDP Annual Growth (%), Forecast, 2014-2020 186

Table 52: Economic Indicators, France, GNI per Capita (USD ), 2008-2013 187

Table 53: Economic Indicators, France, Consumer Price Index, 2008-2013 188

Table 54: Economic Indicators, France, Average Consumer Price Index, Forecast, 2014-2020 189

Table 55: Economic Indicators, France, Average Consumer Price Index Annual Change (%), 2008-2013 190

Table 56: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020 191

Table 57: Economic Indicators, France, Currency Exchange Rate (EUR/USD ), 2008-2013 193

Table 58: Economic Indicators, France, Foreign Direct Investment (USD bn), 2008-2013 194

Table 59: Economic Indicators, France, Foreign Exchange Reserves (USD bn), 2008-2013 195

Table 60: Economic Indicators, France, Imports of Goods and Services (USD bn), 2008-2013 197

Table 61: Economic Indicators, France, Exports of Goods and Services (USD bn), 2008-2013 198

Table 62: Economic Indicators, France, General Government Structural Balance (USD bn), 2008-2013 199

Table 63: Economic Indicators, France, General Government Net Debt (USD bn), 2008-2013 200

Table 64: Economic Indicators, France, Major Industries, Industrial Sector, Gross Value Added (USD bn), 2011-2012 202

Table 65: Demographics, France, Population (million), 2008-2013 203

Table 66: Demographics, France, Population Forecast (million), 2014-2020 204

Table 67: Demographics, France, Population, Urban and Rural Population Share (%), 2008-2013 205

Table 68: Demographics, France, Population, Urban and Rural Population Forecast Share (%), 2014-2020 206

Table 69: Demographics, France, Population Distribution by Age Group (%), 2008-2013 208

Table 70: Demographics, France, Population Distribution by Age Group Forecast (%), 2014-2020 208

Table 71: Demographics, France, Births (per 1,000 Population), 2008-2013 210

Table 72: Demographics, France, Mortality (per 1,000 Population), 2008-2013 211

Table 73: Demographics, France, Major Causes of Mortality (%), 2008 212

Table 74: Demographics, France, Children

Table 75: Demographics, France, Immunization Rate (%), 2008-2013 215

Table 76: Demographics, France, Major Causes of Male Mortality (per 1,000 population), 2008 216

Table 77: Demographics, France, Major Causes of Female Mortality (per 1,000 population), 2008 217

Table 78: Demographics, France, Gender Ratio (M/F), 2008-2013 218

Table 79: Demographics, France, Life Expectancy at Birth (Years), 2008-2013 220

Table 80: Demographics, France, Number of Students by Level of Education (million), 2013-2014 222

Table 81: Demographics, France, Student Enrollment by Specialization (per 1,000 population), 2013 223

Table 82: Demographics, France, Unemployment Rate (%), 2008-2013 224

Table 83: Demographics, France, Major Diseases, DALYs (per 100,000 Population), 2004 226

Table 84: Healthcare Infrastructure, France, Public and Private Hospitals, 2008-2013 227

Table 85: Healthcare Infrastructure, France, Public and Private Hospitals Beds (�000), 2008-2013 228

Table 86: Healthcare Infrastructure, France, Diagnostic Centers, 2008-2013 229

Table 87: Healthcare Infrastructure, France, Diagnostic Units, 2008-2013 230

Table 88: Healthcare Infrastructure, France, Hospitals Beds (per 1,000 Population), 2008-2013 232

Table 89: Healthcare Infrastructure, France, Physicians (per 1,000 Population), 2008-2013 233

Table 90: Healthcare Infrastructure, France, PM10 (�g/m�), 2008-2013 234

Table 91: Healthcare Infrastructure, France, CO2 Emissions (Million Metric Tons), 2008-2013 235

Table 92: Healthcare Infrastructure, France, Nitrates and Orthophosphates Content (%), 2008-2013 237

Table 93: Healthcare Infrastructure, France, Solid Waste (Million Tons), 2008-2013 238

Table 94: Healthcare Infrastructure, France, Nature of Collected Waste (%), 2010 239

Table 95: Healthcare Infrastructure, France, Waste Handling (%), 2012 240

Table 96: Healthcare Infrastructure, France, Nurses (per 100,000 Population), 2008-2013 241

Table 97: Healthcare Infrastructure, France, Pharmacists (per 100,000 Population), 2008-2013 242

Table 98: Healthcare Infrastructure, France, Dentists (per 100,000 Population), 2008-2013 243

Table 99: Healthcare Infrastructure, France, Healthcare Expenditure (% of GDP), 2008-2013 245

Table 100: Healthcare Infrastructure, France, Public-Private Share (%), 2008-2013 246

Table 101: Healthcare Infrastructure, France, Major Components of Healthcare Expenditure (%), 2012 247

Table 102: Healthcare Infrastructure, France, Pharmaceutical R&D Expenditure (USD bn), 2008-2013 249

Table 103: Healthcare Infrastructure, France, Pharmaceutical R&D Expenditure (%), 2011 250

Table 104: Trade Fairs, France, Major Healthcare Trade Fairs, 2014 252

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com